Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This former paratrooper with the 82nd Airborne Division shares his experience with hepatitis C at Hep Stories.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
This is according to an analysis of a large group of veterans.
People without hep C received kidney, liver or heart transplants from HCV-positive donors and then were treated for the virus.
Weight-based Harvoni treatment cured almost almost all of a small group of very young people.
Summaries of some noteworthy hepatitis C research presented at the 2018 Liver Meeting.
The high cost of hepatitis C treatment in the U.S. is about to see a major shift to lower prices of the major leading hepatitis C treatments
The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.
Hepatitis C Patient John, shares his conquering story from hep C, end stage liver disease, liver cancer and liver transplantation.
Part 2 of Connie Welch’s interview with John M, a patient with hepatitis C and cirrhosis, who was successfully treated with Harvoni.
Nevertheless, researchers advise careful kidney monitoring when pairing the medications.
Connie Welch’s interview of John M, who was successfully treated and cured from hepatitis C in 2014 with Harvoni.
With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?
In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.